Aselizumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aselizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target CD62L
Clinical data
Legal status
?
Identifiers
CAS number 395639-53-9 N
ATC code None
Chemical data
Formula ?
 N (what is this?)  (verify)

Aselizumab is an immunosuppressive drug which has been investigated for the use in severely injured patients. It binds to CD62L.[1]

References[edit]

  1. ^ Seekamp, A; Van Griensven, M; Dhondt, E; Diefenbeck, M; Demeyer, I; Vundelinckx, G; Haas, N; Schaechinger, U et al. (2004). "The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trial". Critical Care Medicine 32 (10): 2021–8. doi:10.1097/01.CCM.0000142396.59236.F3. PMID 15483410.